Stock Events

Stock Events

Champions Oncology 

$4.96
6
-$0.22-4.25% Friday 20:00
+$0.01+0.2%Friday 20:04After hours

Statistics

Day High
4.96
Day Low
4.96
52W High
8.74
52W Low
4.83
Volume
1,065
Avg. Volume
-
Mkt Cap
68.91M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

16SepExpected
Q3 2024
Q4 2024
Q2 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.2
-0.01
0.17
0.36
Expected EPS
-0.01
Actual EPS
N/A

Financials

-1.98%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
59.43MRevenue
-1.18MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CSBR. It's not an investment recommendation.
Tesla
2
TSLA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap152.69B
Pfizer is involved in oncology drug development and personalized medicine, competing in the cancer treatment market.
Merck
MRK
Mkt Cap335.14B
Merck is a leading pharmaceutical company with a strong focus on cancer therapies, directly competing in the oncology sector.
Novartis
NVS
Mkt Cap286.78B
Novartis is a global healthcare company that has a significant presence in the development of cancer treatments.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG specializes in biotech treatments for cancer, making it a direct competitor in oncology research.
Bristol-Myers Squibb
BMY
Mkt Cap130.39B
Bristol Myers Squibb is a pharmaceutical company with a strong emphasis on cancer drugs, competing in the oncology market.
Lilly(Eli) &
LLY
Mkt Cap1.05T
Eli Lilly and Company is engaged in the development of oncology products, competing in the cancer treatment space.
Astrazeneca
AZN
Mkt Cap242.64B
AstraZeneca is a biopharmaceutical company focusing on the development of cancer treatments, making it a competitor.
AMGEN
AMGN
Mkt Cap224.63B
Amgen is a biotech firm with a focus on cancer therapeutics, competing in the oncology market.
Gilead Sciences
GILD
Mkt Cap171.56B
Gilead Sciences is involved in the research and development of oncology drugs, making it a competitor in the cancer treatment market.
Regeneron Pharmaceuticals
REGN
Mkt Cap82.72B
Regeneron Pharmaceuticals is engaged in the development of cancer treatments, competing in the oncology sector.

About

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment which is oncology services. Its research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. The company's pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development at lower costs and increased speeds. Its revenue is majorly derived from research services.
Show more...
CEO
Robert Brainin
Employees
214
Country
United States
ISIN
US15870P3073
WKN
000A14X6S

Listings

STU
DE
2I3.STU
MU
DE
2I3.MU
F
DE
2I3.F
XNAS
US
CSBR

0 Comments

Share your thoughts

FAQ

What is Champions Oncology stock price today?▼
The current price of CSBR is $4.96 USD — it has decreased by -4.25% in the past 24 hours. Watch Champions Oncology stock price performance more closely on the chart.
What is Champions Oncology stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Champions Oncology stocks are traded under the ticker CSBR.
Is Champions Oncology stock price growing?▼
CSBR stock has fallen by -2.07% compared to the previous week, the month change is a -19.08% fall, over the last year Champions Oncology has showed a -34.99% decrease.
What is Champions Oncology market cap?▼
Today Champions Oncology has the market capitalization of 68.91M
When is the next Champions Oncology earnings date?▼
Champions Oncology is going to release the next earnings report on September 16, 2026.
What were Champions Oncology earnings last quarter?▼
CSBR earnings for the last quarter are -0.02 USD per share, whereas the estimation was 0.09 USD resulting in a -122.22% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Champions Oncology revenue for the last year?▼
Champions Oncology revenue for the last year amounts to 59.43M USD.
What is Champions Oncology net income for the last year?▼
CSBR net income for the last year is -1.18M USD.
How many employees does Champions Oncology have?▼
As of August 22, 2026, the company has 214 employees.
In which sector is Champions Oncology located?▼
Champions Oncology operates in the Health & Wellness sector.
When did Champions Oncology complete a stock split?▼
The last stock split for Champions Oncology was on August 12, 2015 with a ratio of 1:12.
Where is Champions Oncology headquartered?▼
Champions Oncology is headquartered in BALTIMORE, United States.